Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com

Global Plasma Fractionation Market By Product (Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX), By Sector (Private Sector and Public Sector), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

Published Date : 12-May-2021

Pages: 145

Formats: PDF

The Global Plasma Fractionation Market size is expected to reach $28.2 billion by 2027, rising at a market growth of 9.6% CAGR during the forecast period. Plasma refers to a blood component, obtained from blood by plasmapheresis, and utilized for several therapeutic and medical Products. Human plasma is considered as a source of different proteins. Though, only some of these proteins are beneficial for creating therapeutic plasma products.

The separation process, purification, and extraction of these proteins from the plasma are known as the Plasma fractionation. The proteins obtained from the plasma are majorly classified into major group viz. immunoglobulins, clotting factors, and albumins. Immunoglobulins help in treating various autoimmune diseases and enhance the immune response. Clotting factors are helpful in treating various kinds of blood diseases like hemophilia. Lastly, the albumins are helpful during low albumin levels or fluid loss.

Plasma Fractionation Market Size - Global Opportunities and Trends Analysis Report 2021-2027

The plasma fractionation process is majorly dependent on various aspects like solubility of the products, and their physical & chemical conditions like ionic strengths, pH levels, and temperature, etc. the extracted plasma items, also called as Fresh Frozen Plasma (FFP) which are then subjected to several physical and mechanical treatments for virus inactivation like Chromatography centrifugation, detergent/solvent treatment, Nanofiltration, heat treatment, sterile filtration and ultrafiltration with an aim to attain homogeneity of plasma extracted from various donors and cut down the risks of viral transmissions.

The outbreak of the COVID-19 crisis has influenced each sector across the world. For example, when WHO declared the COVID-19 as global pandemic, nations around the world imposed strict lockdown restrictions to implement social distancing norms as a method to reduce the spread. This results in disruption, restrictions, challenges, and changes in every segment of every industry. Likewise, the plasma fractionation market has also faced some severe impacts by the pandemic. For example, the COVID-19 crisis has resulted in a reduction in the number of blood donations and plasma collections, which restricted the growth of the global plasma fractionation market as it results in the disruption in raw material supply.

Product Outlook

Based on Product, the market is segmented into Immunoglobulins, Albumin, Coagulation factor VIII and Coagulation factor IX. Immunoglobulin procured the maximum revenue share of the plasma fractionation market and would exhibit a promising growth rate during the forecast period. The growth of this segment is due to the varied usage of immunoglobulin in several disorders like primary and secondary immune deficiencies, autoimmune diseases, and inflammatory diseases.

Plasma Fractionation Market Share and Industry Analysis Report 2021-2027

Sector Outlook

Based on Sector, the market is segmented into Private Sector and Public Sector. Based on the sector, the private sector obtained the maximum revenue share of the overall plasma fractionation market in 2020. This is owing to the numerous private players operating in the plasma fractionation market which gather and fractionate a big amount of plasma into derivatives like albumin, immunoglobulin, and others. Therefore, this is likely to push the growth of the overall plasma fractionation market.

Plasma Fractionation Market Report Coverage
Report Attribute Details
Market size value in 2020 USD 17.5 Billion
Market size forecast in 2027 USD 28.2 Billion
Base Year 2020
Historical Period 2017 to 2019
Forecast Period 2021 to 2027
Revenue Growth Rate CAGR of 9.6% from 2021 to 2027
Number of Pages 145
Number of Tables 260
Report coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered Product, Sector, Region
Country scope US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers
  • Immunoglobulins are increasingly used in several therapeutic domains
  • Growing rates of bleeding diseases
Restraints
  • The advent of recombinant alternatives

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific displays attractive opportunities for leading players operating in the plasma fractionation market. This is due to the existence of governmental bodies that control and manage plasma collection, fractionation, and sales are the primary aspects that are fueling the growth of the global plasma fractionation market. Moreover, increasing cases of medical conditions like high fever with thrombocytopenia syndrome (SFTS), hemophilia, and primary & secondary immune deficiencies also propel the development of the market.

Free Valuable Insights: Global Plasma Fractionation Market size to reach USD 28.2 Billion by 2027

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Emergent BioSolutions, Inc., CSL Limited, Grifols S.A., Octapharma AG, Takeda Pharmaceutical Company Limited, Kedrion S.p.A, LFB S.A, Biotest AG (Tiancheng International Investment Limited), Sanquin Blood Supply Foundation, and Bio Products Laboratory Limited.

Recent Strategies Deployed in Plasma Fractionation Market

  • Mar-2021: Octapharma got the U.S. Food and Drug Administration (FDA) approval for two Octapharma supplements to Biological License Applications. These approvals strengthened the company’s pediatric critical care product portfolio.
  • Jan-2021: Octapharma signed an agreement with Akron Biotech. The agreement was focused on producing virally inactivated human AB serum developed from Octaplas for the cell therapy market.
  • Oct-2020: Grifols acquired a plasma fractionation plant, an immunoglobulin and an albumin purification plant in Montreal from the South Korean firm, GC Pharma (Group). In a separate transaction, the company acquired 11 plasma collection centers in the United States property of Green Cross. These acquisitions strengthened Grifols’ presence in Canada.
  • Apr-2020: Kedrion Biopharma collaborated with Kamada Ltd. The collaboration was aimed to develop, manufacture, and distribute human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for coronavirus patients.
  • May-2020: Bio Products Laboratory (BPL) launched ALBUMINEX 5% (human albumin) solution for injection and ALBUMINEX 25% (human albumin) solution for injection in US. These solutions are used for the treatment of hypovolemia, ascites, and hypoalbuminemia including burns, acute nephrosis, acute respiratory distress syndrome (ARDS), and cardiopulmonary bypass.
  • Jun-2017: CSL Limited announced an agreement to acquire 80 percent equity of Wuhan Zhong Yuan Rui De Biological Products Co. Ltd., a plasma-derived therapies manufacturer from Humanwell Healthcare Group Co. Ltd. The acquisition will give CSL a strategic presence in the Chinese domestic plasma fractionation market and would complement the leadership position that its CSL Behring business has built.

Scope of the Study

Market Segments Covered in the Report:

By Product

  • Immunoglobulins
  • Albumin
  • Coagulation factor VIII
  • Coagulation factor IX

By Sector

  • Private Sector
  • Public Sector

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Emergent BioSolutions, Inc.
  • CSL Limited
  • Grifols S.A.
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Kedrion S.p.A
  • LFB S.A
  • Biotest AG (Tiancheng International Investment Limited)
  • Sanquin Blood Supply Foundation
  • Bio Products Laboratory Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Plasma Fractionation Market, by Product
1.4.2 Global Plasma Fractionation Market, by Sector
1.4.3 Global Plasma Fractionation Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Plasma Fractionation Market by Product
3.1 Global Immunoglobulins Market by Region
3.2 Global Albumin Market by Region
3.3 Global Coagulation factor VIII Market by Region
3.4 Global Coagulation factor IX Market by Region

Chapter 4. Global Plasma Fractionation Market by Sector
4.1 Global Private Sector Market by Region
4.2 Global Public Sector Market by Region

Chapter 5. Global Plasma Fractionation Market by Region
5.1 North America Plasma Fractionation Market
5.1.1 North America Plasma Fractionation Market by Product
5.1.1.1 North America Immunoglobulins Market by Country
5.1.1.2 North America Albumin Market by Country
5.1.1.3 North America Coagulation factor VIII Market by Country
5.1.1.4 North America Coagulation factor IX Market by Country
5.1.2 North America Plasma Fractionation Market by Sector
5.1.2.1 North America Private Sector Market by Country
5.1.2.2 North America Public Sector Market by Country
5.1.3 North America Plasma Fractionation Market by Country
5.1.3.1 US Plasma Fractionation Market
5.1.3.1.1 US Plasma Fractionation Market by Product
5.1.3.1.2 US Plasma Fractionation Market by Sector
5.1.3.2 Canada Plasma Fractionation Market
5.1.3.2.1 Canada Plasma Fractionation Market by Product
5.1.3.2.2 Canada Plasma Fractionation Market by Sector
5.1.3.3 Mexico Plasma Fractionation Market
5.1.3.3.1 Mexico Plasma Fractionation Market by Product
5.1.3.3.2 Mexico Plasma Fractionation Market by Sector
5.1.3.4 Rest of North America Plasma Fractionation Market
5.1.3.4.1 Rest of North America Plasma Fractionation Market by Product
5.1.3.4.2 Rest of North America Plasma Fractionation Market by Sector
5.2 Europe Plasma Fractionation Market
5.2.1 Europe Plasma Fractionation Market by Product
5.2.1.1 Europe Immunoglobulins Market by Country
5.2.1.2 Europe Albumin Market by Country
5.2.1.3 Europe Coagulation factor VIII Market by Country
5.2.1.4 Europe Coagulation factor IX Market by Country
5.2.2 Europe Plasma Fractionation Market by Sector
5.2.2.1 Europe Private Sector Market by Country
5.2.2.2 Europe Public Sector Market by Country
5.2.3 Europe Plasma Fractionation Market by Country
5.2.3.1 Germany Plasma Fractionation Market
5.2.3.1.1 Germany Plasma Fractionation Market by Product
5.2.3.1.2 Germany Plasma Fractionation Market by Sector
5.2.3.2 UK Plasma Fractionation Market
5.2.3.2.1 UK Plasma Fractionation Market by Product
5.2.3.2.2 UK Plasma Fractionation Market by Sector
5.2.3.3 France Plasma Fractionation Market
5.2.3.3.1 France Plasma Fractionation Market by Product
5.2.3.3.2 France Plasma Fractionation Market by Sector
5.2.3.4 Russia Plasma Fractionation Market
5.2.3.4.1 Russia Plasma Fractionation Market by Product
5.2.3.4.2 Russia Plasma Fractionation Market by Sector
5.2.3.5 Spain Plasma Fractionation Market
5.2.3.5.1 Spain Plasma Fractionation Market by Product
5.2.3.5.2 Spain Plasma Fractionation Market by Sector
5.2.3.6 Italy Plasma Fractionation Market
5.2.3.6.1 Italy Plasma Fractionation Market by Product
5.2.3.6.2 Italy Plasma Fractionation Market by Sector
5.2.3.7 Rest of Europe Plasma Fractionation Market
5.2.3.7.1 Rest of Europe Plasma Fractionation Market by Product
5.2.3.7.2 Rest of Europe Plasma Fractionation Market by Sector
5.3 Asia Pacific Plasma Fractionation Market
5.3.1 Asia Pacific Plasma Fractionation Market by Product
5.3.1.1 Asia Pacific Immunoglobulins Market by Country
5.3.1.2 Asia Pacific Albumin Market by Country
5.3.1.3 Asia Pacific Coagulation factor VIII Market by Country
5.3.1.4 Asia Pacific Coagulation factor IX Market by Country
5.3.2 Asia Pacific Plasma Fractionation Market by Sector
5.3.2.1 Asia Pacific Private Sector Market by Country
5.3.2.2 Asia Pacific Public Sector Market by Country
5.3.3 Asia Pacific Plasma Fractionation Market by Country
5.3.3.1 China Plasma Fractionation Market
5.3.3.1.1 China Plasma Fractionation Market by Product
5.3.3.1.2 China Plasma Fractionation Market by Sector
5.3.3.2 Japan Plasma Fractionation Market
5.3.3.2.1 Japan Plasma Fractionation Market by Product
5.3.3.2.2 Japan Plasma Fractionation Market by Sector
5.3.3.3 India Plasma Fractionation Market
5.3.3.3.1 India Plasma Fractionation Market by Product
5.3.3.3.2 India Plasma Fractionation Market by Sector
5.3.3.4 South Korea Plasma Fractionation Market
5.3.3.4.1 South Korea Plasma Fractionation Market by Product
5.3.3.4.2 South Korea Plasma Fractionation Market by Sector
5.3.3.5 Singapore Plasma Fractionation Market
5.3.3.5.1 Singapore Plasma Fractionation Market by Product
5.3.3.5.2 Singapore Plasma Fractionation Market by Sector
5.3.3.6 Malaysia Plasma Fractionation Market
5.3.3.6.1 Malaysia Plasma Fractionation Market by Product
5.3.3.6.2 Malaysia Plasma Fractionation Market by Sector
5.3.3.7 Rest of Asia Pacific Plasma Fractionation Market
5.3.3.7.1 Rest of Asia Pacific Plasma Fractionation Market by Product
5.3.3.7.2 Rest of Asia Pacific Plasma Fractionation Market by Sector
5.4 LAMEA Plasma Fractionation Market
5.4.1 LAMEA Plasma Fractionation Market by Product
5.4.1.1 LAMEA Immunoglobulins Market by Country
5.4.1.2 LAMEA Albumin Market by Country
5.4.1.3 LAMEA Coagulation factor VIII Market by Country
5.4.1.4 LAMEA Coagulation factor IX Market by Country
5.4.2 LAMEA Plasma Fractionation Market by Sector
5.4.2.1 LAMEA Private Sector Market by Country
5.4.2.2 LAMEA Public Sector Market by Country
5.4.3 LAMEA Plasma Fractionation Market by Country
5.4.3.1 Brazil Plasma Fractionation Market
5.4.3.1.1 Brazil Plasma Fractionation Market by Product
5.4.3.1.2 Brazil Plasma Fractionation Market by Sector
5.4.3.2 Argentina Plasma Fractionation Market
5.4.3.2.1 Argentina Plasma Fractionation Market by Product
5.4.3.2.2 Argentina Plasma Fractionation Market by Sector
5.4.3.3 UAE Plasma Fractionation Market
5.4.3.3.1 UAE Plasma Fractionation Market by Product
5.4.3.3.2 UAE Plasma Fractionation Market by Sector
5.4.3.4 Saudi Arabia Plasma Fractionation Market
5.4.3.4.1 Saudi Arabia Plasma Fractionation Market by Product
5.4.3.4.2 Saudi Arabia Plasma Fractionation Market by Sector
5.4.3.5 South Africa Plasma Fractionation Market
5.4.3.5.1 South Africa Plasma Fractionation Market by Product
5.4.3.5.2 South Africa Plasma Fractionation Market by Sector
5.4.3.6 Nigeria Plasma Fractionation Market
5.4.3.6.1 Nigeria Plasma Fractionation Market by Product
5.4.3.6.2 Nigeria Plasma Fractionation Market by Sector
5.4.3.7 Rest of LAMEA Plasma Fractionation Market
5.4.3.7.1 Rest of LAMEA Plasma Fractionation Market by Product
5.4.3.7.2 Rest of LAMEA Plasma Fractionation Market by Sector

Chapter 6. Company Profiles
6.1 Emergent BioSolutions, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Grifols S.A.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.1 Recent strategies and developments:
6.3.1.1 Acquisition and Mergers:
6.4 Octapharma AG
6.4.1 Company Overview
6.4.2 Recent strategies and developments:
6.4.2.1 Approvals:
6.4.2.2 Partnerships, Collaborations, and Agreements:
6.5 Takeda Pharmaceutical Company Limited
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Kedrion S.p.A
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 LFB S.A.
6.7.1 Company Overview
6.8 Biotest AG (Tiancheng International Investment Limited)
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Sanquin Blood Supply Foundation
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Bio Products Laboratory Limited
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Product Launches and Product Expansions:
TABLE 1 Global Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 2 Global Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 3 Global Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 4 Global Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 5 Global Immunoglobulins Market by Region, 2017 - 2020, USD Million
TABLE 6 Global Immunoglobulins Market by Region, 2021 - 2027, USD Million
TABLE 7 Global Albumin Market by Region, 2017 - 2020, USD Million
TABLE 8 Global Albumin Market by Region, 2021 - 2027, USD Million
TABLE 9 Global Coagulation factor VIII Market by Region, 2017 - 2020, USD Million
TABLE 10 Global Coagulation factor VIII Market by Region, 2021 - 2027, USD Million
TABLE 11 Global Coagulation factor IX Market by Region, 2017 - 2020, USD Million
TABLE 12 Global Coagulation factor IX Market by Region, 2021 - 2027, USD Million
TABLE 13 Global Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 14 Global Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 15 Global Private Sector Market by Region, 2017 - 2020, USD Million
TABLE 16 Global Private Sector Market by Region, 2021 - 2027, USD Million
TABLE 17 Global Public Sector Market by Region, 2017 - 2020, USD Million
TABLE 18 Global Public Sector Market by Region, 2021 - 2027, USD Million
TABLE 19 Global Plasma Fractionation Market by Region, 2017 - 2020, USD Million
TABLE 20 Global Plasma Fractionation Market by Region, 2021 - 2027, USD Million
TABLE 21 North America Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 22 North America Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 23 North America Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 24 North America Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 25 North America Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 26 North America Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 27 North America Albumin Market by Country, 2017 - 2020, USD Million
TABLE 28 North America Albumin Market by Country, 2021 - 2027, USD Million
TABLE 29 North America Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 30 North America Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 31 North America Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 32 North America Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 33 North America Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 34 North America Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 35 North America Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 36 North America Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 37 North America Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 38 North America Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 39 North America Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 40 North America Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 41 US Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 42 US Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 43 US Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 44 US Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 45 US Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 46 US Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 47 Canada Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 48 Canada Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 49 Canada Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 50 Canada Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 51 Canada Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 52 Canada Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 53 Mexico Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 54 Mexico Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 55 Mexico Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 56 Mexico Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 57 Mexico Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 58 Mexico Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 59 Rest of North America Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 60 Rest of North America Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 61 Rest of North America Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 62 Rest of North America Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 63 Rest of North America Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 64 Rest of North America Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 65 Europe Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 66 Europe Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 67 Europe Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 68 Europe Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 69 Europe Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 70 Europe Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 71 Europe Albumin Market by Country, 2017 - 2020, USD Million
TABLE 72 Europe Albumin Market by Country, 2021 - 2027, USD Million
TABLE 73 Europe Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 74 Europe Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 75 Europe Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 76 Europe Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 77 Europe Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 78 Europe Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 79 Europe Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 80 Europe Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 81 Europe Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 82 Europe Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 83 Europe Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 84 Europe Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 85 Germany Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 86 Germany Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 87 Germany Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 88 Germany Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 89 Germany Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 90 Germany Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 91 UK Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 92 UK Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 93 UK Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 94 UK Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 95 UK Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 96 UK Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 97 France Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 98 France Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 99 France Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 100 France Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 101 France Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 102 France Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 103 Russia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 104 Russia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 105 Russia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 106 Russia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 107 Russia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 108 Russia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 109 Spain Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 110 Spain Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 111 Spain Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 112 Spain Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 113 Spain Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 114 Spain Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 115 Italy Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 116 Italy Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 117 Italy Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 118 Italy Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 119 Italy Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 120 Italy Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 121 Rest of Europe Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 122 Rest of Europe Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 123 Rest of Europe Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 124 Rest of Europe Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 125 Rest of Europe Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 126 Rest of Europe Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 127 Asia Pacific Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 128 Asia Pacific Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 129 Asia Pacific Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 130 Asia Pacific Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 131 Asia Pacific Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 132 Asia Pacific Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 133 Asia Pacific Albumin Market by Country, 2017 - 2020, USD Million
TABLE 134 Asia Pacific Albumin Market by Country, 2021 - 2027, USD Million
TABLE 135 Asia Pacific Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 136 Asia Pacific Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 137 Asia Pacific Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 138 Asia Pacific Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 139 Asia Pacific Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 140 Asia Pacific Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 141 Asia Pacific Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 142 Asia Pacific Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 143 Asia Pacific Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 144 Asia Pacific Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 145 Asia Pacific Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 146 Asia Pacific Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 147 China Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 148 China Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 149 China Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 150 China Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 151 China Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 152 China Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 153 Japan Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 154 Japan Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 155 Japan Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 156 Japan Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 157 Japan Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 158 Japan Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 159 India Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 160 India Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 161 India Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 162 India Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 163 India Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 164 India Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 165 South Korea Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 166 South Korea Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 167 South Korea Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 168 South Korea Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 169 South Korea Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 170 South Korea Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 171 Singapore Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 172 Singapore Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 173 Singapore Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 174 Singapore Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 175 Singapore Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 176 Singapore Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 177 Malaysia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 178 Malaysia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 179 Malaysia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 180 Malaysia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 181 Malaysia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 182 Malaysia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 183 Rest of Asia Pacific Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 184 Rest of Asia Pacific Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 185 Rest of Asia Pacific Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 186 Rest of Asia Pacific Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 187 Rest of Asia Pacific Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 188 Rest of Asia Pacific Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 189 LAMEA Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 190 LAMEA Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 191 LAMEA Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 192 LAMEA Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 193 LAMEA Immunoglobulins Market by Country, 2017 - 2020, USD Million
TABLE 194 LAMEA Immunoglobulins Market by Country, 2021 - 2027, USD Million
TABLE 195 LAMEA Albumin Market by Country, 2017 - 2020, USD Million
TABLE 196 LAMEA Albumin Market by Country, 2021 - 2027, USD Million
TABLE 197 LAMEA Coagulation factor VIII Market by Country, 2017 - 2020, USD Million
TABLE 198 LAMEA Coagulation factor VIII Market by Country, 2021 - 2027, USD Million
TABLE 199 LAMEA Coagulation factor IX Market by Country, 2017 - 2020, USD Million
TABLE 200 LAMEA Coagulation factor IX Market by Country, 2021 - 2027, USD Million
TABLE 201 LAMEA Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 202 LAMEA Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 203 LAMEA Private Sector Market by Country, 2017 - 2020, USD Million
TABLE 204 LAMEA Private Sector Market by Country, 2021 - 2027, USD Million
TABLE 205 LAMEA Public Sector Market by Country, 2017 - 2020, USD Million
TABLE 206 LAMEA Public Sector Market by Country, 2021 - 2027, USD Million
TABLE 207 LAMEA Plasma Fractionation Market by Country, 2017 - 2020, USD Million
TABLE 208 LAMEA Plasma Fractionation Market by Country, 2021 - 2027, USD Million
TABLE 209 Brazil Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 210 Brazil Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 211 Brazil Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 212 Brazil Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 213 Brazil Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 214 Brazil Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 215 Argentina Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 216 Argentina Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 217 Argentina Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 218 Argentina Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 219 Argentina Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 220 Argentina Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 221 UAE Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 222 UAE Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 223 UAE Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 224 UAE Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 225 UAE Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 226 UAE Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 227 Saudi Arabia Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 228 Saudi Arabia Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 229 Saudi Arabia Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 230 Saudi Arabia Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 231 Saudi Arabia Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 232 Saudi Arabia Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 233 South Africa Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 234 South Africa Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 235 South Africa Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 236 South Africa Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 237 South Africa Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 238 South Africa Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 239 Nigeria Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 240 Nigeria Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 241 Nigeria Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 242 Nigeria Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 243 Nigeria Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 244 Nigeria Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 245 Rest of LAMEA Plasma Fractionation Market, 2017 - 2020, USD Million
TABLE 246 Rest of LAMEA Plasma Fractionation Market, 2021 - 2027, USD Million
TABLE 247 Rest of LAMEA Plasma Fractionation Market by Product, 2017 - 2020, USD Million
TABLE 248 Rest of LAMEA Plasma Fractionation Market by Product, 2021 - 2027, USD Million
TABLE 249 Rest of LAMEA Plasma Fractionation Market by Sector, 2017 - 2020, USD Million
TABLE 250 Rest of LAMEA Plasma Fractionation Market by Sector, 2021 - 2027, USD Million
TABLE 251 Key Information – Emergent BioSolutions, Inc.
TABLE 252 key Information – CSL Limited
TABLE 253 key information – Grifols S.A.
TABLE 254 Key Information – Octapharma AG
TABLE 255 Key Information – Takeda Pharmaceutical Company Limited
TABLE 256 key Information – Kedrion S.p.A
TABLE 257 Key Information – LFB S.A
TABLE 258 key information – Biotest AG
TABLE 259 Key Information – Sanquin Blood Supply Foundation
TABLE 260 Key Information – Bio Products Laboratory Limited

List of Figures
FIG 1 Methodology for the research

Purchase Full Report of
Plasma Fractionation Market

Buy Now

Avail up to 60% discount on subscription plans on

SUBSCRIPTION MODEL